These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 35708087)

  • 21. Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells.
    Nakagawa Y; Nakayama H; Nagata M; Yoshida R; Kawahara K; Hirosue A; Tanaka T; Yuno A; Matsuoka Y; Kojima T; Yoshitake Y; Hiraki A; Shinohara M
    Int J Oncol; 2014 Apr; 44(4):1376-84. PubMed ID: 24452447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibronectin and colorectal cancer: signaling pathways and clinical implications.
    Wang J; Li R; Li M; Wang C
    J Recept Signal Transduct Res; 2021 Aug; 41(4):313-320. PubMed ID: 32900261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ins and outs of fibronectin matrix assembly.
    Wierzbicka-Patynowski I; Schwarzbauer JE
    J Cell Sci; 2003 Aug; 116(Pt 16):3269-76. PubMed ID: 12857786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibronectin degradation by human gastric carcinoma cell lines and its associated proteases in relation to stromal invasion in nude mice.
    Wakabayashi H; Kawaguchi T
    Invasion Metastasis; 1992; 12(5-6):284-300. PubMed ID: 1298740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression.
    Ioachim E; Charchanti A; Briasoulis E; Karavasilis V; Tsanou H; Arvanitis DL; Agnantis NJ; Pavlidis N
    Eur J Cancer; 2002 Dec; 38(18):2362-70. PubMed ID: 12460779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix.
    Flies DB; Langermann S; Jensen C; Karsdal MA; Willumsen N
    Front Immunol; 2023; 14():1199513. PubMed ID: 37662958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor.
    Verfaillie CM; Benis A; Iida J; McGlave PB; McCarthy JB
    Blood; 1994 Sep; 84(6):1802-11. PubMed ID: 7521691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibronectin-bound TNF-alpha stimulates monocyte matrix metalloproteinase-9 expression and regulates chemotaxis.
    Vaday GG; Hershkoviz R; Rahat MA; Lahat N; Cahalon L; Lider O
    J Leukoc Biol; 2000 Nov; 68(5):737-47. PubMed ID: 11073115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type III and V collagens modulate the expression and assembly of EDA(+) fibronectin in the extracellular matrix of defective Ehlers-Danlos syndrome fibroblasts.
    Zoppi N; Ritelli M; Colombi M
    Biochim Biophys Acta; 2012 Oct; 1820(10):1576-87. PubMed ID: 22705941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments.
    Yuan Z; Li Y; Zhang S; Wang X; Dou H; Yu X; Zhang Z; Yang S; Xiao M
    Mol Cancer; 2023 Mar; 22(1):48. PubMed ID: 36906534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The strength of the protein-material interaction determines cell fate.
    González-García C; Cantini M; Ballester-Beltrán J; Altankov G; Salmerón-Sánchez M
    Acta Biomater; 2018 Sep; 77():74-84. PubMed ID: 30006313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.
    Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP
    BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIFα independent mechanisms in renal carcinoma cells modulate divergent outcomes in fibronectin assembly mediated by hypoxia and CoCl
    Magdaleno C; Dixon L; Rajasekaran N; Varadaraj A
    Sci Rep; 2020 Oct; 10(1):18560. PubMed ID: 33122751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proinvasive extracellular matrix remodeling for tumor progression.
    Kaushik N; Kim S; Suh Y; Lee SJ
    Arch Pharm Res; 2019 Jan; 42(1):40-47. PubMed ID: 30515725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TNF-alpha disruption of lung endothelial integrity: reduced integrin mediated adhesion to fibronectin.
    Rotundo RF; Curtis TM; Shah MD; Gao B; Mastrangelo A; LaFlamme SE; Saba TM
    Am J Physiol Lung Cell Mol Physiol; 2002 Feb; 282(2):L316-29. PubMed ID: 11792637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment.
    Lv D; Fei Y; Chen H; Wang J; Han W; Cui B; Feng Y; Zhang P; Chen J
    Front Immunol; 2024; 15():1340702. PubMed ID: 38690275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of matrix assembly through rigidity-dependent fibronectin conformational changes.
    Carraher CL; Schwarzbauer JE
    J Biol Chem; 2013 May; 288(21):14805-14. PubMed ID: 23589296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteolysis of decellularized extracellular matrices results in loss of fibronectin and cell binding activity.
    Ramanathan A; Karuri N
    Biochem Biophys Res Commun; 2015 Apr; 459(2):246-251. PubMed ID: 25724944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consequences of Extracellular Matrix Remodeling in Headway and Metastasis of Cancer along with Novel Immunotherapies: A Great Promise for Future Endeavor.
    Ray SK; Mukherjee S
    Anticancer Agents Med Chem; 2022; 22(7):1257-1271. PubMed ID: 34254930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibronectin amyloid-like aggregation alters its extracellular matrix incorporation and promotes a single and sparsed cell migration.
    Bascetin R; Blay L; Kellouche S; Carreiras F; Picot CR; Briand M; Agniel R; Gallet O; Vendrely C; Leroy-Dudal J
    Exp Cell Res; 2018 Oct; 371(1):104-121. PubMed ID: 30076804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.